-
-
Small Molecule Drug Platforms
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Oral Fast Dissolving Technology
显示更多 -
-
Peptide Platforms
显示更多 -
Research Team
-
“Jiuzhou on the list of “Zhejiang Famous Brand for Export” in 2022
Release time:
2023-11-09
In order to strengthen the cultivation of famous export brands, enhance the international competitiveness of export products, and promote the high-quality development of foreign trade, the Department of Commerce of Zhejiang Province has started the declaration and evaluation of “Zhejiang Famous Export Brands” in 2022. Recently, the Department of Commerce of Zhejiang Province announced the list of “Zhejiang Famous Brand for Export”. Our “Jiuzhou” brand was honored again in this review.
In the pharmaceutical and chemical industry, competition is intensifying internationally, as an innovative drug CDMO enterprise, Jiuzhou Pharmaceuticals, with innovative and internationalized vision of brand building, continues to forge brand strength, cultivate competitive advantages, and create its own brand advantages. At the same time, the company is the leading export enterprise of “Quality Zhejiang Products”, and is the AA class enterprise of Taizhou Pharmaceutical Enterprise Customs. Successfully obtaining the customs AEO certification of foreign trade “gold standard”, enhance the trust of the company's overseas customers, improve the competitiveness of the enterprise's international market, for the development of the industry to build momentum and empowerment.
In the future, Jiuzhou Pharmaceutical will make every effort to promote the integrated business of CDMO “API+Preparation”, continuously improve the competitiveness of Jiuzhou brand, accelerate the clinical research and commercialization of innovative drugs, and escort the rapid globalization of innovative drugs.
Other News
2026-11-10
Winter Process Chemistry Conference
2026-11-03
2026-11-03
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services(API)
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com